Original Query: ALL
Previous Study | Return to List | Next Study

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00495144
Recruitment Status : Completed
First Posted : July 2, 2007
Last Update Posted : July 27, 2012
Information provided by (Responsible Party):
Threshold Pharmaceuticals

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : December 2011
  Study Completion Date : June 2012

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 July 14, 2017 December 11, 2017